Price
16.14
+4.39%52W Range
Market Cap
₹1,517.16 Cr
Traded: ₹11.61 Cr (0.77%) 0.0x
Free Float: ₹746.90 Cr (1.55% of FF traded)
Volume · 60D trend
71.96 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Return | +21.0% | +11.0% | +24.0% | -30.0% | -- | Stable |
| ROE | -- | +13.0% | +16.0% | -- | -- | Accelerating |
| Sales | +10.0% | -- | +30.0% | -- | +6.0% | Stable |
| Profit | +22.0% | -- | +57.0% | -- | +56.0% | Stable |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 135 | 115 | 122 | 117 | 149 | 128 | 102 | 87 | 75 | 65 | 64 | 60 | 61 | 57 | 54 |
| Expenses | 113 | 94 | 103 | 101 | 131 | 113 | 90 | 77 | 65 | 58 | 57 | 53 | 55 | 51 | 50 |
| Operating Profit | 22 | 21 | 18 | 16 | 18 | 15 | 12 | 10 | 9 | 7 | 6 | 6 | 6 | 6 | 4 |
| OPM % | 16.0% | 18.0% | 15.0% | 14.0% | 12.0% | 12.0% | 12.0% | 12.0% | 13.0% | 11.0% | 10.0% | 11.0% | 10.0% | 10.0% | 8.0% |
| Other Income | 15 | 6 | 5 | 6 | 7 | 4 | 4 | 1 | 3 | 5 | 4 | 2 | 7 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 34 | 25 | 22 | 20 | 23 | 17 | 15 | 10 | 10 | 9 | 8 | 6 | 10 | 6 | 5 |
| Tax % | 25.0% | 25.0% | 25.0% | 22.0% | 24.0% | 25.0% | 25.0% | 24.0% | 26.0% | 25.0% | 23.0% | 28.0% | 18.0% | 30.0% | 33.0% |
| Net Profit | 25 | 19 | 17 | 16 | 18 | 13 | 11 | 8 | 7 | 7 | 7 | 4 | 8 | 4 | 4 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Sales Growth (YoY) | -9.4% | -10.2% | 19.6% | 34.5% | 98.7% | 96.9% | 59.4% | 45.0% | 22.9% | 14.0% | 18.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 17.4% | -5.7% | 4.3% | -21.5% | 16.4% | 25.5% | 17.2% | 16.0% | 15.4% | 1.6% | 6.7% | -1.6% | 7.0% | 5.6% | -- |
| OP Growth (YoY) | 22.2% | 40.0% | 50.0% | 60.0% | 100.0% | 114.3% | 100.0% | 66.7% | 50.0% | 16.7% | 50.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 4.8% | 16.7% | 12.5% | -11.1% | 20.0% | 25.0% | 20.0% | 11.1% | 28.6% | 16.7% | 0.0% | 0.0% | 0.0% | 50.0% | -- |
| Profit Growth (YoY) | 42.4% | 45.5% | 49.4% | 106.0% | 138.9% | 85.2% | 70.7% | 73.4% | -12.5% | 69.6% | 81.3% | 13.7% | 77.4% | 3.2% | -36.1% |
| EPS Growth (YoY) | 42.1% | 42.9% | 50.0% | 112.5% | 137.5% | 100.0% | 71.4% | 60.0% | -11.1% | 75.0% | 75.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 35.0% | 11.1% | 5.9% | -10.5% | 35.7% | 16.7% | 50.0% | 0.0% | 14.3% | 0.0% | 40.0% | -44.4% | 125.0% | 0.0% | -- |
| OP Margin | 16.3% | 18.3% | 14.8% | 13.7% | 12.1% | 11.7% | 11.8% | 11.5% | 12.0% | 10.8% | 9.4% | 10.0% | 9.8% | 10.5% | 7.4% |
| Net Margin | 18.5% | 16.5% | 13.9% | 13.7% | 12.1% | 10.2% | 10.8% | 9.2% | 9.3% | 10.8% | 10.9% | 6.7% | 13.1% | 7.0% | 7.4% |
| Material Cost % | 62.0% | 53.0% | 58.0% | 59.0% | 67.0% | 68.0% | 64.0% | 62.0% | 57.0% | 61.0% | 61.0% | 59.0% | 61.0% | 61.0% | 67.0% |
| Employee Cost % | 13.0% | 15.0% | 14.0% | 14.0% | 10.0% | 11.0% | 12.0% | 11.0% | 12.0% | 15.0% | 14.0% | 13.0% | 12.0% | 13.0% | 12.0% |
| P/S | 3.10 | 2.71 | 2.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 19.68 | 19.58 | 18.81 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.66 | 3.60 | 3.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50PURSUANT TO REG 30 SEBI, LODR, WE HEREBY SUBMIT THE PRESS RELEASE ISSUED BY THE COMPANY
Submission of Press Clipping Related to extract of Un-Audited Standalone and Consolidated Financial Result for the Quarter ended on 30th June, 2026.
Disclosure under Regulation 30(2) read with Clause 7 of Para A of Schedule /// of the SEBI (LODR) Regulation, 2015: Change in directors, KMP and Senior Management.
Corporate Announcement/Information pursuant to Regulation 44 of the SEBI (LODR) Regulation, 2015 regarding providing Remote E-Voting facilities for the 38th Annual General Meeting to be ....
Appointment of Cost Auditor and Internal Auditor for the FY 2026-27.
Pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report thereon ....
We are pleased to inform you that, pursuant to the provision of Regulation 42 of SEBI (LODR) Regulations, 2015 and Section 91 of the Companies Act, 2013 the "Record Date" has been fixed ....
Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.
Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations, 2015.
Intimation for Resignation of Mr. Kedarmal Shankarlal Bankda Whole-Time Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirement) Regulation, 2015
Intimation for Resignation of Mr. Rahul Vijay Bankda Chief Financial Officer (CFO) under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015
Intimation for Resignation of Mr. Vijay Shankarlal Bankda Managing Director under Regulation 30 of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday ....
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve we are pleased to ....
Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th June, 2026
Notice for Trading window Closure for the financials of the quarter ended 30.06.2026
Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026
Pursuant to regulation 33(3)(d) of SEBI LODR Regulations, 2015 we are pleased to submit the financials for the year ended on 31st March, 2026
Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by ....
In terms of REG 24A of Listing Regulations, as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March, 2026
In terms of REG 24A of Listing Regulations, as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March, 2026
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Pursuant to Reg 30 we want to inform that the company has purchased a property
Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) Regulation, 2018 for the quarter ended 31st March, 2026
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Pursuant to the regulation 31(4) of SEBI (SAST) Regulations, 2011, we would like to inform that the following promoters along with their persons acting in concert have provided a copy of ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Pursuant to SEBI (PIT) Regulation, 2015 as amended till date, the window for trading in the shares of the company shall remain closed form 1st April 2026 till completion of 48 hours after ....
Submission of Press Clipping Related to extract of Un-Audited Financial Result for the Quarter and Nine months ended on 31st December, 2025
Submission of Unaudited standalone and Consolidated Financials as an outcome of Board meeting held on 12th February, 2026
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st December, 2025
Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation, 2018 for the quarter ended 31st December, 2025.
Pursuant to Regulation 30 read with Schedule lll Part A of SEBI (LODR) Regulations, 2015 for the demand raised under section 74(5) of CGST Act, 2017 for Ineligible Input Tax Credits also ....
Closure of Trading Window for the quarter ending 31.12.2025 pursuant to SEBI(PIT)REG, 2015
we hereby inform the Exchange that the company''s bid for the acquisition of a commercial property has been accepted by HDFC Bank Ltd, which is material in nature.
Submission of press clipping related to extract of unaudited quarter/half year ended financial results for the quarter/half year ended on 30th September 2025
This is in continuation of our letter no. SYNCOM/SE/2025-26 dated 7th November, 2025 regarding intimation of Board meeting for consideration and approval of Standalone and Consolidated ....
Submission of Unaudited Standalone and consolidated Financial results for the Quarter ended 30.09.2025
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Corporate Announcement ....
Certificate for compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 30th September, 2025
Appointment of Secretarial Auditor confirmed in 37th AGM
Alteration in MOA and AOA as approved in the 37th AGM
Change in Management_Appointment of Chairman and Secreterial Auditor as confirmed in the 37th Annual general Meeting
Outcome of 37th Annual General meeting held on 29th Sep, 2025
Submission of Results for the 37th Annual general meeting held on 29th Sep, 2025
Proceedings of 37th Annual General Meeting held on 29th September, 2025
NOTICE OF TRADING WINDOW CLOSURE IN THE SHARES OF THE COMPANY FOR THE QUARTER AND HALF YEAR ENDED 30.09.2025
NEWSPAPER PUBLICATION OF AGM NOTICE, BOOK CLOSURE REMOTE E-VOTING, AND OTHER DETAILS.
Business Responsibility and Sustainability Report 2024-25
Held by ETFs
1 ETFs hold SYNCOMF · sorted by weight
Held by Mutual Funds
1 schemes hold SYNCOMF · sorted by weight